Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 28, 2023

Association Between Treatment With GnRH Agonists and Atherogenic Lipid Levels in Patients With Prostate Cancer With Type 2 Diabetes Mellitus

British Journal of Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Cancer
Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
Br. J. Cancer 2022 Dec 15;[EPub Ahead of Print], E Lin, H Garmo, E Hagström, M Van Hemelrijck, J Adolfsson, P Stattin, B Zethelius, D Crawley

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading